Burnet Institute has unveiled an ambitious new strategic blueprint, Burnet 2020, to make a greater contribution and impact in improving the health of vulnerable communities in Australia and globally.
Burnet 2020 will refine the Institute’s focus by transforming Burnet into a program-led organisation to enhance our unique approach of linking medical research to practical action, and ability to respond to the most devastating global health issues.
Burnet Institute Director and CEO Professor Brendan Crabb AC said Burnet 2020 would more effectively harness the Institute’s unique breadth, diversity and skill base to help develop creative and effective solutions to ambitious goals through new research.
“We believe that every person in the world has an equal right to basic healthcare,” Professor Crabb said. “To achieve this for the world’s most neglected people requires both commitment and innovation."
Burnet Chair, Mr Robert Milne described Burnet 2020 as the natural next step in the Institute’s outstanding 30-year track record in tackling global health issues such as malaria, HIV, hepatitis C and tuberculosis.
“After a lifetime in business, I am proud to lead the Burnet Institute Board, an amazing, independent organisation that is improving the health of vulnerable communities in Australia and many locations across the globe,” Mr Milne said.
Burnet 2020 will more fully exploit our international and local field presence, our laboratories, and our mixed development and research cultures to translate research and evidence into practical solutions.
Central to Burnet 2020 is an organisational restructure placing interdisciplinary health programs at the heart of daily decision-making.
Our focus will be on Maternal and Child Health, Disease Elimination, and Behaviours and Health Risks, with a fourth theme, Expansion Programs, created to develop two areas of increasing research importance, Health Security and Healthy Ageing.
Burnet 2020 will incorporate a partnership approach to build on our close links with communities in Myanmar, Papua New Guinea, China, Africa and Lao PDR, and provide new opportunities to promote the embedding of research into health systems in developing countries.